HomeCompareMKLNF vs GBDC

MKLNF vs GBDC: Dividend Comparison 2026

MKLNF yields 5.05% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $11.27M in total portfolio value
10 years
MKLNF
MKLNF
● Live price
5.05%
Share price
$11.73
Annual div
$0.59
5Y div CAGR
66.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.58M
Annual income
$7,703,093.13
Full MKLNF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — MKLNF vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMKLNFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MKLNF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MKLNF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MKLNF
Annual income on $10K today (after 15% tax)
$429.30/yr
After 10yr DRIP, annual income (after tax)
$6,547,629.16/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $7,435,494.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MKLNF + GBDC for your $10,000?

MKLNF: 50%GBDC: 50%
100% GBDC50/50100% MKLNF
Portfolio after 10yr
$15.22M
Annual income
$12,076,913.49/yr
Blended yield
79.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

MKLNF
No analyst data
Altman Z
7.0
Piotroski
7/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MKLNF buys
0
GBDC buys
0
No recent congressional trades found for MKLNF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMKLNFGBDC
Forward yield5.05%11.86%
Annual dividend / share$0.59$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR66.1%51.1%
Portfolio after 10y$9.58M$20.85M
Annual income after 10y$7,703,093.13$16,450,733.83
Total dividends collected$9.39M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: MKLNF vs GBDC ($10,000, DRIP)

YearMKLNF PortfolioMKLNF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$11,539$838.90$12,492$1,791.70$953.00GBDC
2$13,849$1,502.66$16,527$3,160.58$2.7KGBDC
3$17,618$2,799.68$23,588$5,904.90$6.0KGBDC
4$24,381$5,528.83$37,141$11,901.65$12.8KGBDC
5$37,964$11,876.70$66,205$26,463.38$28.2KGBDC
6$69,330$28,708.39$137,452$66,612.65$68.1KGBDC
7$155,568$81,384.90$342,372$195,298.53$186.8KGBDC
8$449,942$283,484.73$1,053,292$686,954.33$603.4KGBDC
9$1,754,217$1,272,778.40$4,111,439$2,984,416.95$2.36MGBDC
10$9,580,105$7,703,093.13$20,849,974$16,450,733.83$11.27MGBDC

MKLNF vs GBDC: Complete Analysis 2026

MKLNFStock

M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty and Trade. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine and cosmetic dermatology, as well as trades in pharmaceutical, biosimilars, and other medical products and devices in the areas of oncology, HIV, rheumatism, neurology, cardiovascular diseases, and narcotics. The company also engages in the acquisition, management, and sale of real estate, primarily in the health care sector. It offers its products to doctors, pharmacies, and wholesalers under the M1 Select brand. The company operates a network of outpatient specialist centers; and a specialized surgical clinic center, as well as 46 specialist centers under the M1 Med Beauty brand. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.

Full MKLNF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this MKLNF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MKLNF vs SCHDMKLNF vs JEPIMKLNF vs OMKLNF vs KOMKLNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.